HOLON, Israel (AP) — HOLON, Israel (AP) — Compugen Ltd. (CGEN) on Tuesday reported a fourth-quarter loss of $6.1 million, after reporting a profit in the same period a year earlier.
The Holon, Israel-based company said it had a loss of 7 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 7 cents per share.
The drug developer posted revenue of $1.5 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $17.5 million.
For the year, the company reported that its loss narrowed to $14.2 million, or 16 cents per share. Revenue was reported as $27.9 million.
The company's shares closed at $1.81. A year ago, they were trading at $2.64.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。